202 related articles for article (PubMed ID: 19339938)
1. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
Silverberg MJ; Abrams DI
Curr Opin HIV AIDS; 2009 Jan; 4(1):42-51. PubMed ID: 19339938
[TBL] [Abstract][Full Text] [Related]
2. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
3. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
4. Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
Chammartin F; Mocroft A; Egle A; Zangerle R; Smith C; Mussini C; Wit F; Vehreschild JJ; d'Arminio Monforte A; Castagna A; Bailly L; Bogner J; de Wit S; Matulionyte R; Law M; Svedhem V; Tallada J; Garges HP; Marongiu A; Borges ÁH; Jaschinski N; Neesgaard B; Ryom L; Bucher HC;
Clin Infect Dis; 2024 Apr; 78(4):995-1004. PubMed ID: 38092042
[TBL] [Abstract][Full Text] [Related]
5. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
[TBL] [Abstract][Full Text] [Related]
6. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
Silverberg MJ; Abrams DI
Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
[TBL] [Abstract][Full Text] [Related]
7. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
8. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
9. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
10. Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk.
Borges AH; Dubrow R; Silverberg MJ
Curr Opin HIV AIDS; 2014 Jan; 9(1):34-40. PubMed ID: 24225382
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and the risk of cancers with and without a known infectious cause.
Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
[TBL] [Abstract][Full Text] [Related]
12. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
Brickman C; Palefsky JM
Curr HIV/AIDS Rep; 2015 Dec; 12(4):388-96. PubMed ID: 26475669
[TBL] [Abstract][Full Text] [Related]
13. Non-AIDS-defining cancers and HIV infection.
Lim ST; Levine AM
Curr HIV/AIDS Rep; 2005 Aug; 2(3):146-53. PubMed ID: 16091262
[TBL] [Abstract][Full Text] [Related]
14. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
15. [HIV-related malignancies: state of art].
Gobert A; Mounier N; Lavole A; Poizot-Martin I; Spano JP
Bull Cancer; 2014 Nov; 101(11):1020-9. PubMed ID: 25418594
[TBL] [Abstract][Full Text] [Related]
16. The growing problem of non-AIDS-defining malignancies in HIV.
Pantanowitz L; Schlecht HP; Dezube BJ
Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
[TBL] [Abstract][Full Text] [Related]
17. CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.
Bower M; Fisher M; Hill T; Reeves I; Walsh J; Orkin C; Phillips AN; Bansi L; Gilson R; Easterbrook P; Johnson M; Gazzard B; Leen C; Pillay D; Schwenk A; Anderson J; Porter K; Gompels M; Sabin CA;
Haematologica; 2009 Jun; 94(6):875-80. PubMed ID: 19336735
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
19. Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.
Trickey A; May MT; Gill MJ; Grabar S; Vehreschild J; Wit FWNM; Bonnet F; Cavassini M; Abgrall S; Berenguer J; Wyen C; Reiss P; Grabmeier-Pfistershammer K; Guest JL; Shepherd L; Teira R; d'Arminio Monforte A; Del Amo J; Justice A; Costagliola D; Sterne JAC
Int J Cancer; 2020 Jun; 146(11):3134-3146. PubMed ID: 32003460
[TBL] [Abstract][Full Text] [Related]
20. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.
Bedimo RJ; McGinnis KA; Dunlap M; Rodriguez-Barradas MC; Justice AC
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):203-8. PubMed ID: 19617846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
